https://www.fool.com/investing/2019/09/30/why-immunomedics-inc-stock-is-sinking-today.aspx
Why Immunomedics Stock Is Sinking Today | The Motley Fool
Sep 30, 2019 - The market isn't pleased with its latest clinical update.
the motleyimmunomedicsstocksinkingtoday
https://www.biospace.com/immunomedics-inc-reports-humanized-anti-cd20-antibody-appears-safe-and-active-in-non-hodgkin-s-lymphoma
Immunomedics, Inc. Reports Humanized Anti-CD20 Antibody Appears Safe And Active In Non-Hodgkin's...
https://www.biospace.com/immunomedics-inc-presents-updated-results-with-sacituzumab-govitecan-in-lung-cancer
Immunomedics, Inc. Presents Updated Results With Sacituzumab Govitecan in Lung Cancer - BioSpace
https://www.biospace.com/immunomedics-inc-reports-first-clinical-experience-with-new-generation-of-bispecific-antibody
Immunomedics, Inc. Reports First Clinical Experience With New Generation of Bispecific Antibody -...
clinical experience
https://www.biospace.com/immunomedics-inc-release-new-diagnostic-assay-for-pancreatic-cancer-reported-in-b-journal-of-clinical-oncology-b
Immunomedics, Inc. Release: New Diagnostic Assay For Pancreatic Cancer Reported In Journal Of...
https://www.pymnts.com/cpi-posts/gilead-focuses-on-cancer-treatments-with-21b-immunomedics-deal/
Gilead Focuses On Cancer Treatments With $21B Immunomedics Deal | PYMNTS.com
Sep 15, 2020 - Gilead Sciences Inc. agreed to acquire Immunomedics Inc. for about $21 billion, a substantial premium for the maker of a promising breast-cancer therapy, and...
cancer treatmentsgileadfocuses
https://www.biospace.com/immunomedics-inc-awarded-additional-patent-for-pegylation-method
Immunomedics, Inc. Awarded Additional Patent for PEGylation Method - BioSpace
immunomedicsincawardedadditionalpatent
https://www.biospace.com/immunomedics-s-breast-cancer-drug-wins-breakthrough-tag-from-the-fda
Immunomedics's Breast Cancer Drug Wins Breakthrough Tag from the FDA - BioSpace
breast cancer
https://www.biospace.com/immunomedics-inc-announces-proposed-offering-of-85-million-of-convertible-senior-notes-due-2020
Immunomedics, Inc. Announces Proposed Offering of $85 Million of Convertible Senior Notes Due 2020...
https://www.fool.com/investing/2017/05/05/why-immunomedics-mercadolibre-and-pearson-jumped-t.aspx
Why Immunomedics, MercadoLibre, and Pearson Jumped Today | The Motley Fool
May 5, 2017 - These stocks helped lead the market higher. Find out why.
the motleyimmunomedicsmercadolibrepearsonjumped
https://www.oanda.com/eu-nl/trading/shares/us/immunomedics
Immunomedics Inc (IMMU) Handelen | Aandelen CFD's | OANDA
Handel in aandelen van Immunomedics Inc (IMMU) met OANDA. Bekijk live grafieken en de huidige marktrente voor dit aandeel.
immunomedicsinchandelenaandelencfd
https://www.biospace.com/immunomedics-inc-to-present-at-the-society-of-nuclear-medicine-56th-annual-meeting
Immunomedics, Inc. to Present At the Society of Nuclear Medicine 56th Annual Meeting - BioSpace
society of nuclear medicine
https://www.prnewswire.com/news-releases/why-investors-love-these-biotechs-stocks---immunogen-immunomedics-vanda-pharma-and-arrowhead-pharma-585021921.html
Why Investors Love These Biotech's Stocks? - ImmunoGen, Immunomedics, Vanda Pharma, and Arrowhead...
/PRNewswire/ -- Lagging the market yesterday was the Biotech space, which continues to be challenged by costs, economic uncertainty, and policies....